Retraction
The Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol in the Treatment of COPD in the Elderly
Paper Information
Record ID:
48397
Journal:
Publication Date:
August 17, 2022
Retraction Date:
July 19, 2023
(2.3 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institution:
Department of Respiration, General Hospital of Pingxiang Mining Industry Group Co., Ltd, Pingxiang 337000, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9819710Additional Notes:
See also: https://pubpeer.com/publications/BA15DEEFFA0E47495D9944F5C6F4DD
Citations (3)
3
Total Citations1
Post-Retraction(33.3%)
0
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
107
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Efficacy of β2-adrenergic receptor agonist combined with corticosteroid in the treatment of children with cough variant asthma
Junyi Cao, Yingchun Wang, Xiao-Xia Deng
World Journal of Clinical Cases
Open Access
Published: Nov 2023
3 citations
3 citations
107 days after retraction
Retracted: The Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol in the Treatment of COPD in the Elderly
Contrast Media Molecular Imaging
Contrast Media & Molecular Imaging
Open Access
Published: Jul 2023
Same day as retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
2.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025